Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × alvimopan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Constipation 5 Intestinal Diseases 4 Pain 3 Neoplasms 3 Urinary Bladder Neoplasms 2 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Opioid-Induced Constipation 1 Ileus 1 Fallopian Tube Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 21 Paclitaxel 20 Cisplatin 17 Cytoreduction Surgical Procedures 16 Oxaliplatin 13 Carboplatin 12 Fluorouracil 9 Bevacizumab 9 Mitomycin 6 Doxorubicin 6 Leucovorin 5 Docetaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Blood Specimen Collection 4 sodium thiosulfate 3 catumaxomab 3 Gemcitabine 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 130-nm albumin-bound paclitaxel 3 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 liposomal doxorubicin 2 Taxes 2 Palliative Care 2 Observation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03352414 2021-08-18

ILEUS

University of California, San Diego

Phase 2 Terminated

84 enrolled 10 charts

Peritoneal Neoplasms, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡